Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2023 Earnings Call Transcript

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2023 Earnings Call Transcript May 11, 2023

Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.2.

Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q1 2023 Earnings Conference. Before we begin, I would like to remind you that this call will contain forward-looking statements, concerning Heron’s future expectations, plans, prospects,...